Drug lookup
Drug reference

umeclidinium bromide

Long-acting muscarinic antagonist (LAMA), anticholinergic · Bronchodilator

Long-acting muscarinic antagonist (LAMA), anticholinergicBronchodilator
CDSCO approved
EXCRETION
not curated
INTERACTIONS
none in our sources
PREGNANCY
not curated

Mechanism

Umeclidinium bromide is a long-acting muscarinic antagonist. It acts as a competitive antagonist of endogenous acetylcholine (ACh) at muscarinic receptors, inhibiting the direct constrictor effect on bronchial smooth muscle. It antagonizes vagally mediated airway tone, leading to bronchodilation and reduced mucus secretion. Its clinical effects are very similar to tiotropium.

Indications

COPDSevere asthma (as an additional bronchodilator when not adequately controlled with maximal ICS/LABA therapy)

Pharmacokinetics

Duration
24+ h

Side effects

Common
Dryness of the mouthUrinary retention

Related guidelines

Other Long-acting muscarinic antagonist (LAMA), anticholinergic drugs

Ask House about umeclidinium bromide

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team